APA

Sarrazin C., Manns M., Calleja J. L., Garcia-Samaniego J., Forns X., Kaste R., Bai X., Wu J. & Stern J. O. (20170718). HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment. : PloS one.

Chicago

Sarrazin Christoph, Manns Michael, Calleja Jose Luis, Garcia-Samaniego Javier, Forns Xavier, Kaste Renee, Bai Xiaofei, Wu Jing and Stern Jerry O. 20170718. HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment. : PloS one.

Harvard

Sarrazin C., Manns M., Calleja J. L., Garcia-Samaniego J., Forns X., Kaste R., Bai X., Wu J. and Stern J. O. (20170718). HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment. : PloS one.

MLA

Sarrazin Christoph, Manns Michael, Calleja Jose Luis, Garcia-Samaniego Javier, Forns Xavier, Kaste Renee, Bai Xiaofei, Wu Jing and Stern Jerry O. HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment. : PloS one. 20170718.